JETEMA, Co., Ltd. (KOSDAQ:216080)
6,230.00
+170.00 (2.81%)
At close: Dec 29, 2025
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 224.33 billion as of December 30, 2025. Its market cap has decreased by -37.00% in one year.
Market Cap
224.33B
Enterprise Value
330.40B
Revenue
75.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,230.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 224.33B, an increase of 73.75%. That is a compound annual growth rate of 9.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |